When TAP Pharmaceutical Products Inc.'s national account executive Janice Swirski offered Joseph Gerstein, MD, an administrator with Tufts Health Plan, a $40,000 “unrestricted educational grant” to put TAP's drug Lupron on Tufts' formulary — she picked the wrong doctor for a bribe. For years, Gerstein has written newsletters deriding pharma marketing practices. But TAP had gone too far. Gerstein reported the incident to federal prosecutors, and helped them build a case that resulted in the ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to GOVERNMENT HANDCUFFS PHARMA MARKETING, you'll get exclusive access to a large archive of premium content.

Already registered? here.